A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults
Bulletin du Cancer, 06/22/2012
Bourget P et al. – The experiment strongly contributes to the safety and security of the medication circuit at the hospital and, improves the performance of allogeneic hematopoietic stem–cell transplant (allo–SCT). It also contributes to the protection of all actors in the health field and their working environment via a well–functioning quality management system.
